It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2009.
2009 | New Delhi, Delhi, India | ActiveDermawell Pharmaceuticals Private Limited, a active private limited company, was established on 03 December 2009 in New Delhi, Delhi, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U36100DL2009PTC196601. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Sanjay Midha (Additional Director), Amit Seth (Director), Deepali Seth (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-308, Defence Colony, New Delhi, Delhi, 110024.
U36100DL2009PTC196601
196601
03 December 2009
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Dermawell Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Midha | Additional Director | 25 Oct 2011 | Current |
| Amit Seth | Director | 03 Dec 2009 | Current |
| Deepali Seth | Director | 03 Dec 2009 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dermawell Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Dermawell Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dermawell Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dermawell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dermawell Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Dermawell Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Dermawell Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Sanjay Midha was appointed as a Additional Director was appointed as a Additional Director on 25 Oct 2011 & has been associated with this company since 14 years 1 month . was completed.
The activity Amit Seth was appointed as a Director was appointed as a Director on 03 Dec 2009 & has been associated with this company since 15 years 11 months . was completed.
Progress on Deepali Seth was appointed as a Director was appointed as a Director on 03 Dec 2009 & has been associated with this company since 15 years 11 months . was documented.
Progress on Dermawell Pharmaceuticals Private Limited was registered on 03 Dec 2009 with Roc Delhi & aged 15 years 11 months as per MCA records. was documented.
The CIN of Dermawell Pharmaceuticals Private Limited is U36100DL2009PTC196601.
Dermawell Pharmaceuticals Private Limited is headquartered at C-308, Defence Colony, New Delhi, Delhi, 110024.
Dermawell Pharmaceuticals Private Limited was incorporated on 03 December 2009.
The current directors of Dermawell Pharmaceuticals Private Limited are
The primary industry of Dermawell Pharmaceuticals Private Limited is Hospital And Medical Care.
Dermawell Pharmaceuticals Private Limited is unlisted.
The authorized capital of Dermawell Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Dermawell Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX